Neuronal Membrane-Derived Nanodiscs for Broad-Spectrum Neurotoxin Detoxification.
Abstract
Neurotoxins pose significant challenges in defense and healthcare due to their disruptive effects on nervous tissues. Their extreme potency and enormous structural diversity have hindered the development of effective antidotes. Motivated by the properties of cell membrane-derived nanodiscs, such as their ultrasmall size, disc shape, and inherent cell membrane functions, here, we develop neuronal membrane-derived nanodiscs (denoted "Neuron-NDs") as a countermeasure nanomedicine for broad-spectrum neurotoxin detoxification. We fabricate Neuron-NDs using the plasma membrane of human SH-SY5Y neurons and demonstrate their effectiveness in detoxifying tetrodotoxin (TTX) and botulinum toxin (BoNT), two model toxins with distinct mechanisms of action. Cell-based assays confirm the ability of Neuron-NDs to inhibit TTX-induced ion channel blockage and BoNT-mediated inhibition of synaptic vesicle recycling. In mouse models of TTX and BoNT intoxication, treatment with Neuron-NDs effectively improves survival rates in both therapeutic and preventative settings. Importantly, high-dose administration of Neuron-NDs shows no observable acute toxicity in mice, indicating its safety profile. Overall, our study highlights the facile fabrication of Neuron-NDs and their broad-spectrum detoxification capabilities, offering promising solutions for neurotoxin-related challenges in biodefense and therapeutic applications.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 시술 | botulinum toxin
|
보툴리눔독소 주사 | dict | 1 | |
| 해부 | Neuronal
|
scispacy | 1 | ||
| 해부 | Nanodiscs
|
scispacy | 1 | ||
| 해부 | nervous tissues
|
scispacy | 1 | ||
| 해부 | cell membrane-derived nanodiscs
|
scispacy | 1 | ||
| 해부 | cell membrane
|
scispacy | 1 | ||
| 해부 | neuronal membrane-derived nanodiscs
|
scispacy | 1 | ||
| 해부 | broad-spectrum neurotoxin
|
scispacy | 1 | ||
| 해부 | plasma membrane
|
scispacy | 1 | ||
| 약물 | tetrodotoxin
|
C0039705
Tetrodotoxin
|
scispacy | 1 | |
| 약물 | TTX
→ tetrodotoxin
|
C0039705
Tetrodotoxin
|
scispacy | 1 | |
| 약물 | high-dose
|
scispacy | 1 | ||
| 약물 | BoNT
→ botulinum toxin
|
scispacy | 1 | ||
| 약물 | broad-spectrum
|
scispacy | 1 | ||
| 질환 | toxicity
|
C0040539
Toxicity aspects
|
scispacy | 1 | |
| 기타 | Neurotoxin
|
scispacy | 1 | ||
| 기타 | human SH-SY5Y neurons
|
scispacy | 1 | ||
| 기타 | TTX-induced
|
scispacy | 1 | ||
| 기타 | synaptic vesicle
|
scispacy | 1 | ||
| 기타 | mouse
|
scispacy | 1 | ||
| 기타 | mice
|
scispacy | 1 |
MeSH Terms
Humans; Neurons; Animals; Mice; Tetrodotoxin; Neurotoxins; Nanostructures; Cell Membrane; Botulinum Toxins; Inactivation, Metabolic
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- Local therapeutic strategies for neurocutaneous dysesthesia: from capsaicin to cannabinoids.
- Comparative efficacy of intralesional therapies for keloid scars: a network meta-analysis.
- Adverse neurological events following botulinum toxin type A: A case series of post-injection seizures and paralysis.
- Decreased utilization of component separation techniques over time in complex abdominal wall reconstruction following introduction of preoperative botulinum toxin A.
- Current Perspectives on Pectoralis Minor Syndrome: A Narrative Review.